Pharmaceuticals
Drugs may get cheaper with 35% cap on trading margin
19 Jan 2016
On some medicines chemists and wholesalers charge margins as high as 2,000 to 3,000 per cent, which points to the huge difference between the cost of medicines to retailer and the selling price
Shire to buy US biotech firm Baxalta for $32 bn
12 Jan 2016
Baxalta offers Shire a promising range of new products to complement its expanding portfolio of high-priced treatments for rare or "orphan" diseases